Nutritional Supplementation May Interfere With Cancer Treatment

Commentary
Video

According to Denise B. Reynolds, RD, patients eating well should not be experiencing nutritional deficiencies during cancer treatment.

In an interview with CancerNetwork® on nutrition during cancer treatment, Denise B. Reynolds, RD, discussed whether she observes deficiencies in vitamins or minerals among patients undergoing treatment for cancer, as well as her recommendations for supplementation.

Reynolds, a registered dietitian at Atrium Health Levine Cancer, suggested that patients who are eating well should not be experiencing any nutritional deficiencies while undergoing cancer treatment, except in unique cases. Those experiencing anemia whose red blood cells are breaking down may benefit from iron supplementation or infusion but should speak with a physician first. Additionally, vitamin D deficiencies may emerge, requiring supplementation.

Beyond potential iron and vitamin D supplementation, Reynolds recommends shying away from “high-powered” supplementation meant to boost the immune system, as these may interfere with chemotherapy or radiation.

Transcript:

It is different for every cancer, and cancer treatment is individualized. There are issues. For example, if you have nausea and vomiting, then you are [likely] losing a lot of fluid [and] you are not keeping the calories down. Overall, if someone is eating well, they should not be deficient in any specific vitamins. Now, the cancer treatment itself can cause anemia, because you are breaking down cells––breaking down red blood cells. A physician may ask that you take iron or may have an iron infusion. If you are deficient in vitamin D, which so many of us are, even without cancer, they might recommend a vitamin D supplement. Other than that, we do not recommend any supplements while you are receiving cancer care.

Certain supplements can be high in, say, antioxidants, and that can interfere with the chemotherapy [or] radiation. For [patients] who do not recognize that, they [may] have friends and family who give them high-powered supplements or drink something that helps boost their immune system, so to speak. We do not want that. That can interfere with some of the treatment that we offer our patients.

Recent Videos
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Surgery and radiation chemotherapy can affect immunotherapy’s ability to target tumor cells in the nervous system, according to John Henson, MD.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Related Content